GlassScriptPhysician profile
Florina Neagu
NPI 1588807333
$15,807.43
in general payments reported to CMS, 2019-2025
51 companies · $3,526 in 2025
The $3,526 reported for 2025 was more than what 80% of Allergy & Immunology providers received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $367 · 2021: $1,847 · 2022: $2,456 · 2023: $3,927 · 2024: $2,790 · 2025: $3,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,999 · Consulting Fee: $1,215 · Education: $29.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,998.74 |
| Consulting Fee | $1,215.00 |
| Education | $29.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,276.46 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Genzyme Corporation | $2,257.61 | 2020-2025 | |
| Genentech USA, INC. | $1,662.79 | 2019-2025 | Xolair |
| Takeda Pharmaceuticals U.S.A., INC. | $1,512.83 | 2020-2025 | Cuvitru, Takhzyro, Hyqvia |
| Glaxosmithkline, LLC. | $1,282.03 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $1,092.57 | 2019-2025 | Dupixent |
| Csl Behring | $710.64 | 2020-2025 | Haegarda, Andembry, Hizentra |
| Pfizer INC. | $516.86 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $453.78 | 2020-2025 | |
| Novo Nordisk INC | $304.50 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Mannkind Corporation | $236.73 | 2020-2021 | |
| Grifols USA, LLC | $221.25 | 2022-2025 | Xembify |
| Octapharma USA, INC. | $211.45 | 2022-2024 | Octagam Immune Globulin (Human), Panzyga, Cutaquig |
| Amgen INC. | $206.99 | 2019-2023 | Evenity, Prolia |
| Horizon Therapeutics Plc | $204.56 | 2021-2022 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $165.42 | 2022-2024 | |
| Kaleo, INC. | $165.40 | 2020-2023 | Auvi-Q |
| Biocryst US Sales Co., LLC | $160.14 | 2021-2024 | Orladeyo |
| Xeris Pharmaceuticals, INC. | $156.79 | 2024-2025 | Gvoke Hypopen, Recorlev |
| Lilly USA, LLC | $151.84 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Dexcom, INC. | $147.39 | 2023-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $131.25 | 2022-2025 | |
| Ibsa Pharma INC. | $128.94 | 2023-2025 | Tirosint, Licart, Tirosint |
| Radius Health, INC. | $122.42 | 2024 | Tymlos |
| Optinose US, INC. | $118.93 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $106.15 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $104.12 | 2024-2025 | Omnipod |
| Antares Pharma, INC. | $97.80 | 2024-2025 | Xyosted |
| Ionis Pharmaceuticals, INC. | $89.20 | 2025 | Dawnzera |
| Incyte Corporation | $88.93 | 2022-2025 | Opzelura |
| Abbott Laboratories | $87.41 | 2023-2024 | Freestyle Libre 3 |
| Pharming Healthcare, INC. | $79.00 | 2023-2024 | Ruconest |
| Esperion Therapeutics, INC. | $73.98 | 2024-2025 | Nexletol |
| Almatica Pharma LLC | $61.83 | 2024-2025 | Teriparatide |
| Medtronic, INC. | $46.33 | 2025 | Propel |
| Beta Bionics, INC. | $45.50 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Shire North American Group INC | $32.78 | 2019 | |
| Kyowa Kirin, INC. | $28.17 | 2023 | Crysvita |
| Uswm, LLC | $25.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $24.49 | 2021 | |
| Alexion Pharmaceuticals, INC. | $24.03 | 2024 | Strensiq |
| Circassia INC. | $23.20 | 2024 | Niox |
| Amneal Pharmaceuticals LLC | $22.37 | 2025 | Unithroid |
| Nevro Corp. | $22.27 | 2024 | Senza |
| Merck Sharp & Dohme LLC | $21.58 | 2023 | |
| Vivus LLC | $20.55 | 2023 | Qsymia |
| Gc Biopharma USA, INC. | $18.29 | 2025 | Alyglo |
| Galderma Laboratories, L.P. | $17.73 | 2025 | Nemluvio |
| Corcept Therapeutics | $16.27 | 2024 | Korlym |
| Hikma Pharmaceuticals USA | $16.26 | 2023 | Ryaltris |
| Phadia US INC. | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florina Neagu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.